224 related articles for article (PubMed ID: 15855032)
1. Acceleration of cisplatin ototoxicity by perilymphatic application of 4-methylthiobenzoic acid.
Cappaert NL; Klis SF; Wijbenga J; Smoorenburg GF
Hear Res; 2005 May; 203(1-2):80-7. PubMed ID: 15855032
[TBL] [Abstract][Full Text] [Related]
2. Summating potential in the guinea pig cochlea after perilymphatic perfusion with arginine-vasopressin.
Lohuis PJ; Klis SF; van Emst MG; Smoorenburg GF
Acta Otolaryngol; 2001 Dec; 121(8):896-901. PubMed ID: 11813891
[TBL] [Abstract][Full Text] [Related]
3. Distribution of platinum in blood and perilymph in relation to cisplatin induced ototoxicity in the guinea pig.
Sepmeijer JW; Klis SF
Hear Res; 2009 Jan; 247(1):34-9. PubMed ID: 18955125
[TBL] [Abstract][Full Text] [Related]
4. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
Muldoon LL; Pagel MA; Kroll RA; Brummett RE; Doolittle ND; Zuhowski EG; Egorin MJ; Neuwelt EA
Clin Cancer Res; 2000 Jan; 6(1):309-15. PubMed ID: 10656463
[TBL] [Abstract][Full Text] [Related]
5. Recovery of hearing following cisplatin ototoxicity in the guinea pig.
O'Leary SJ; Klis SF
Anticancer Res; 2002; 22(3):1525-8. PubMed ID: 12168832
[TBL] [Abstract][Full Text] [Related]
6. Perilymphatic application of alpha-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin.
Wolters FL; Klis SF; Hamers FP; de Groot JC; Smoorenburg GF
Hear Res; 2004 Mar; 189(1-2):31-40. PubMed ID: 14987750
[TBL] [Abstract][Full Text] [Related]
7. A method for introducing non-silencing siRNA into the guinea pig cochlea in vivo.
Sellick P; Layton MG; Rodger J; Robertson D
J Neurosci Methods; 2008 Jan; 167(2):237-45. PubMed ID: 17945347
[TBL] [Abstract][Full Text] [Related]
8. The role of antioxidants in protection from ototoxic drugs.
Sergi B; Fetoni AR; Ferraresi A; Troiani D; Azzena GB; Paludetti G; Maurizi M
Acta Otolaryngol Suppl; 2004 May; (552):42-5. PubMed ID: 15219046
[TBL] [Abstract][Full Text] [Related]
9. Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model.
Berglin CE; Pierre PV; Bramer T; Edsman K; Ehrsson H; Eksborg S; Laurell G
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1547-56. PubMed ID: 21533919
[TBL] [Abstract][Full Text] [Related]
10. Ototoxic protection of sodium thiosulfate: daily vs constant infusion.
Stocks RM; Gould HJ; Bush AJ; Dudney BW; Pousson M; Thompson JW
Otolaryngol Head Neck Surg; 2004 Jul; 131(1):115-9. PubMed ID: 15243567
[TBL] [Abstract][Full Text] [Related]
11. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells.
Kopke RD; Liu W; Gabaizadeh R; Jacono A; Feghali J; Spray D; Garcia P; Steinman H; Malgrange B; Ruben RJ; Rybak L; Van de Water TR
Am J Otol; 1997 Sep; 18(5):559-71. PubMed ID: 9303151
[TBL] [Abstract][Full Text] [Related]
12. [Effects of perilymphatic perfusion with cisplatin on the cochlear potential in guinea pigs].
Wu DZ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Aug; 25(4):202-4, 254. PubMed ID: 2076322
[TBL] [Abstract][Full Text] [Related]
13. Suppressing effect of substance P receptor antagonist on sound evoked potentials recorded from the guinea pig cochlea.
Liang X; Wang Z; Zhang L; Ni D
Chin Med J (Engl); 1999 Feb; 112(2):129-31. PubMed ID: 11593577
[TBL] [Abstract][Full Text] [Related]
14. Protection by 4-methylthiobenzoic acid against cisplatin-induced ototoxicity: antioxidant system.
Rybak LP; Husain K; Evenson L; Morris C; Whitworth C; Somani SM
Pharmacol Toxicol; 1997 Oct; 81(4):173-9. PubMed ID: 9353848
[TBL] [Abstract][Full Text] [Related]
15. Effects of CO2/HCO3- in perilymph on the endocochlear potential in guinea pigs.
Nimura Y; Mori Y; Inui T; Sohma Y; Takenaka H; Kubota T
J Physiol Sci; 2007 Feb; 57(1):15-22. PubMed ID: 17169167
[TBL] [Abstract][Full Text] [Related]
16. Reversible cisplatin ototoxicity in the albino guinea pig.
Klis SF; O'Leary SJ; Hamers FP; De Groot JC; Smoorenburg GF
Neuroreport; 2000 Feb; 11(3):623-6. PubMed ID: 10718325
[TBL] [Abstract][Full Text] [Related]
17. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
[TBL] [Abstract][Full Text] [Related]
18. High concentrations of thiosulfate in scala tympani perilymph after systemic administration in the guinea pig.
Pierre PV; Engmér C; Wallin I; Laurell G; Ehrsson H
Acta Otolaryngol; 2009 Feb; 129(2):132-7. PubMed ID: 18607994
[TBL] [Abstract][Full Text] [Related]
19. [Effects of lowering perilymph calcium concentration on various cochlear potentials].
Wang J; Dong WJ; Chen JS; Liu JL
Sheng Li Xue Bao; 1994 Aug; 46(4):327-32. PubMed ID: 7973823
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin and cisplatin ototoxicity in guinea pigs.
Taudy M; Syka J; Popelár J; Ulehlová L
Audiology; 1992; 31(5):293-9. PubMed ID: 1449432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
